These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26163879)

  • 1. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.
    Tao R; Hu S; Wang S; Zhou X; Zhang Q; Wang C; Zhao X; Zhou W; Zhang S; Li C; Zhao H; He Y; Zhu S; Xu J; Jiang Y; Li L; Gao Y
    Carcinogenesis; 2015 Oct; 36(10):1136-43. PubMed ID: 26163879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke.
    Zheng Z; Liu S; Wang C; Han X
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3535-3541. PubMed ID: 30197169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
    Tang Y; Wang Y; Wang X; Liu Y; Zheng K
    Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A.
    Yuan J; Zhang N; Zheng Y; Chen YD; Liu J; Yang M
    DNA Cell Biol; 2018 Sep; 37(9):750-757. PubMed ID: 30074406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk.
    Zhu Z; Gao X; He Y; Zhao H; Yu Q; Jiang D; Zhang P; Ma X; Huang H; Dong D; Wan J; Gu Z; Jiang X; Yu L; Gao Y
    Cancer Res; 2012 Dec; 72(23):6163-72. PubMed ID: 23026137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis.
    Shen Z; She Q
    Cell Physiol Biochem; 2018; 49(4):1431-1443. PubMed ID: 30205366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An indel polymorphism within pre-miR3131 confers risk for hepatocellular carcinoma.
    Wang C; Li L; Yin Z; Zhang Q; Zhao H; Tao R; Wang S; Hu S; He Y; Wang D; Li C; Zhang S; Xu J; Jiang X; Zhu S; Gao Y
    Carcinogenesis; 2017 Feb; 38(2):168-176. PubMed ID: 28034876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin.
    Chang L; Li C; Lan T; Wu L; Yuan Y; Liu Q; Liu Z
    Mol Med Rep; 2016 Feb; 13(2):1541-50. PubMed ID: 26707238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21.
    Hu L; Ye H; Huang G; Luo F; Liu Y; Liu Y; Yang X; Shen J; Liu Q; Zhang J
    Tumour Biol; 2016 Feb; 37(2):2691-702. PubMed ID: 26404135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of LncRNA-GAS5 gene polymorphisms and PBMC LncRNA-GAS5 level with risk of systemic lupus erythematosus in Chinese population.
    Liu CH; Lu YL; Huang HT; Wang CF; Luo HC; Wei GJ; Lei M; Tan T; Wang Y; Huang YY; Wei YS; Lan Y
    J Cell Mol Med; 2021 Apr; 25(7):3548-3559. PubMed ID: 33728802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA-GAS5 and its Promoter Region Polymorphism Associate with Helper Th17 Polarization and Predict Postoperative Pain and the Prognosis of the Patients with Hepatocellular Carcinoma Undergoing Hepatectomy.
    Sha Z; Zhang P
    Iran J Immunol; 2022 Dec; 19(4):349-357. PubMed ID: 36585876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
    Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
    Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer.
    Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer.
    Li Q; Ma G; Sun S; Xu Y; Wang B
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):478-482. PubMed ID: 29602737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.
    Wang C; Zhao H; Zhao X; Wan J; Wang D; Bi W; Jiang X; Gao Y
    Tumour Biol; 2014 Jan; 35(1):295-301. PubMed ID: 23918301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma.
    Xiong XD; Fang JH; Qiu FE; Zhao J; Cheng J; Yuan Y; Li SP; Zhuang SM
    Mutat Res; 2008 Aug; 643(1-2):70-4. PubMed ID: 18640135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional insertion/deletion polymorphism in the promoter of PDCD6IP is associated with the susceptibility of hepatocellular carcinoma in a Chinese population.
    Yu Q; Zhou C; Wang J; Chen L; Zheng S; Zhang J
    DNA Cell Biol; 2013 Aug; 32(8):451-7. PubMed ID: 23777424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Variants of
    Deng F; Zhu P; Liao C; Li S; Hu X; Wang Y; Wu Z; Huang S; Zhong W; Zhao B; Ma G; Li Y
    Biomed Res Int; 2021; 2021():6634253. PubMed ID: 33937403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer.
    Wang Y; Wu S; Yang X; Li X; Chen R
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30902880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
    Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.